ImPact Biotech is a biotechnology company focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy, a novel oncology technology platform aimed at treating a range of solid tumors at both localized and metastatic stages.
Focus Areas
Notable Investments
